News and Events

The future of DUB research is promising, with the potential for discovering safe and effective cancer therapy inhibitors and beyond. Discover DUBs from Biortus on our comprehensive Biologics platform.

Rita Gaidar and Anna Kapeliukha send best wishes from RICT 2024! Stop by our posters #P135 and #P92 to explore collaboration opportunities.

Molsoft's new GINGER software generates high-quality conformer libraries super fast on GPUs. Combined with Enamine REAL products, we at Chemspace offer unique services like RIDE and RIDGE screenings. Learn more about our Virtual Screening services here.

We are excited to participate in RICT 2024 in Bordeaux, France, from July 3-5. Schedule a meeting with us to discuss potential collaboration.

Summer special offer: buy antibodies and get free samples from ProSci! All the details here.

The latest issue of the "Building Blocks for Drug Candidates" series! Discover key analogs to a potential drug - Seltorexant, a promising treatment for major depressive disorder and insomnia.

Our General Pre-Plated Library now includes over 862K molecules. Explore and download it now.

Check out the latest Chemspace co-authored article, exploring how AlphaFold2 models expand the realm of structure-based ligand discovery!

Join Olena Strapak at the 38th ACS National Medicinal Chemistry Symposium in Seattle on June 23-26! Schedule a personal meeting to discover potential collaboration opportunities.

Get a CCK-8 kit (1 ml, 100 tests) from TargetMol for just 1 USD/EUR with any order. Read more here.

Check out our latest Biologics campaign post, focusing on Spleen Tyrosine Kinase (Syk). Follow the link and explore a set of Chemspace Biologics specially selected for studying Syk-related diseases. 

Have you been missing our 'Weekend article' feature? If so, we have a treat for you! Follow the link below to explore a new approach to creating dual agonists using Machine Learning.

Welcome to a new post in your favorite #Meet_Chemspace_Team series! Introducing our account manager, Olena Liutikova! Click the link to discover more about her.

Here is a summary of all Chemspace news and highlights for May, in case you missed it.

PI3Kα(H1047R) inhibitors were designed to target a specific mutation that plays a key role in certain cancers, particularly breast cancer. Click the link to explore what we have for you.

We are happy to present the first result of our collaboration with NexMR – Photoinducible Fragment Library! Read more here.

Uliana Matviienko and Aliona Savitch send best wishes from SLAS 2024 in Barcelona!

We are delighted to continue our series in Molecule Builder!
 
Tovorafenib, also known by the brand name Ojemda®, is an oral medication classified as a type II RAF inhibitor.

Meet us at SLAS 2024 in Barcelona! From May 27th to May 29th, chat with Uliana Matviienko, our Supply Chain Director, and Aliona Savitch, Product Owner. See you there!

Happy National Vyshyvanka Day! Let each stitch in your vyshyvanka be a symbol of our cultural heritage and unity. Wishing you joy with loved ones and endless inspiration! Thank you for staying with us and Ukraine. 

Until July 31, we offer up to 50%-off discounted prices for the list of small molecules by TargetMol. Read more here.

We continue our "Meet Chemspace Team" post series! Introducing our senior account manager, Alina Kolosovska! Click the link to discover more about her.

Discover key analog molecules for fragments of a potential drug such as CRN04894, a promising treatment for Cushing syndrome in the last issue of the "Building Blocks for Drug Candidates" series. Find them here.

We are summarizing the latest updates from Chemspace. Check out our April post roundup!

In March, the FDA approved Danicopan (Voydeya®) for treating chronic, progressive and potentially life-threatening blood disorder. This drug's backbone includes a 3-fluoropyrrolidine moiety. Explore 3-fluoropyrrolidine-based compounds for your research!